Our laboratory works at the intersection of medicine, pharmacy, and materials science with the overarching goals of improving drug efficacy and patient compliance while developing minimally invasive diagnostic devices. Our research focuses on the design of biomaterials for drug‑delivery applications, including advanced oral formulations, long‑acting injectable systems, nanoparticles for the delivery of genetic material, and microneedles for the non‑invasive administration of diagnostic and therapeutic agents. We increasingly integrate computational methods to optimize formulation design, analyze complex datasets, and accelerate the development of innovative delivery platforms. Among other projects, our group is also a pioneer in the development of fluorescent medical tattoos designed for non‑invasive, wearable monitoring of pathological parameters.